Search Results 1181-1190 of 17811 for monoclonal antibody

  1. Cholangiocarcinoma Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...

  2. A Controlled Clinical Study Of Dupilumab In Patients With Nasal Polyps

    Any experimental monoclonal antibody (mAB) within 5 half-lives or within 6 months before V1 if the half-life is unknown. Anti-immunoglobulin E (IgE) therapy ...

  3. A Study of the Structural Parts of Bone in Related Diseases that Have Increased Risk of Fractures - Mayo Clinic

    ... monoclonal gammopathies (related diseases in which patients have an increased risk of fracture). Participation eligibility. Participant eligibility includes ...

  4. A Study Of Pirtobrutinib And Brexucabtagene Autoleucel In Relapsed Or Refractory Mantle Cell Lymphoma - Mayo Clinic

    Targeted agents (i.e. BTK inhibitors), investigational agents, therapeutic monoclonal antibodies ... Antibody-drug conjugates (ADC): 10 weeks. Radiation ...

  5. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia - Mayo Clinic

    At least 14 days since prior monoclonal antibody therapy; No more than 1 prior autologous or allogeneic hematopoietic stem cell transplantation. No evidence ...

  6. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

    History of ≥ Grade 3 allergic reactions to monoclonal antibody therapy as well as known or suspected allergy or intolerance to any agent given in the course of ...

  7. Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease - Mayo Clinic News Network

    Vincent Rajkumar, a Mayo Clinic hematologist and researcher, discusses herd immunity, antibodies and how the body works to fight off disease. Dr. Bret Petersen, ...

  8. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

    ... monoclonal antibodies (Grade ≥ 3 National Cancer Institute [NCI]-Common ... antibody, or anti-4-1BB antibody is not allowed, inclusive of localized ...

  9. Study in Pediatrics with HypEREosinophilic Syndrome - Mayo Clinic

    Participants who have received any other monoclonal antibodies ... Participants with any history of hypersensitivity to any monoclonal antibody (including ...

  10. Biomarker-guided CNI substitution in Kidney Transplantation Assessment - Mayo Clinic

    anti-Tumor necrosis factor(TNF) Monoclonal antibodies (mAb), or Belatacept, abatacept, ... Positive for a Donor Specific Antibody (DSA) 0-6 months post-kidney ...